SB-559457

antineoplastic for myeloid leukemia cells; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Gewirtz, Alan M: 1 article (01/2010)
2.	Kalota, Anna: 1 article (01/2010)

1.	Myeloid Leukemia (Leukemia, Myelocytic) 01/07/2010 - "A prototype nonpeptidyl, hydrazone class, thrombopoietin receptor agonist, SB-559457, is toxic to primary human myeloid leukemia cells."
2.	Leukemia 01/07/2010 - "Biologic characterization of SB-559457 (SB), a nonpeptidyl hydrazone class of thrombopoietin receptor (Mpl) agonist, revealed toxicity toward human leukemia cells. "